G Clifton

635 total citations
24 papers, 530 citations indexed

About

G Clifton is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, G Clifton has authored 24 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in G Clifton's work include Glutathione Transferases and Polymorphisms (6 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Blood Pressure and Hypertension Studies (4 papers). G Clifton is often cited by papers focused on Glutathione Transferases and Polymorphisms (6 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Blood Pressure and Hypertension Studies (4 papers). G Clifton collaborates with scholars based in United States, Australia and United Kingdom. G Clifton's co-authors include Neil Kaplowitz, John D. Wallin, J Kuhlenkamp, Prasad Turlapaty, Atul Laddu, William M. OʼNeill, Herbert G. Langford, William Smith, Marcia Poland and Ramón Vargas and has published in prestigious journals such as The American Journal of Medicine, Hypertension and The American Journal of Cardiology.

In The Last Decade

G Clifton

24 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Clifton United States 13 245 155 119 57 55 24 530
Koichi Moriguchi Japan 9 174 0.7× 61 0.4× 295 2.5× 73 1.3× 15 0.3× 22 741
M. J. Lee South Korea 6 82 0.3× 48 0.3× 165 1.4× 61 1.1× 30 0.5× 6 481
G. H. Hirsch United States 13 123 0.5× 90 0.6× 38 0.3× 18 0.3× 21 0.4× 30 485
MA Robin France 6 180 0.7× 139 0.9× 26 0.2× 54 0.9× 61 1.1× 8 661
Supriya R. Kulkarni United States 10 248 1.0× 80 0.5× 22 0.2× 52 0.9× 31 0.6× 10 499
Leyla C. Ramirez France 9 332 1.4× 128 0.8× 37 0.3× 126 2.2× 51 0.9× 23 805
Kimie Imai Japan 13 113 0.5× 42 0.3× 46 0.4× 17 0.3× 23 0.4× 33 507
Robert Scheig United States 15 174 0.7× 58 0.4× 47 0.4× 176 3.1× 136 2.5× 36 861
Shivani Mittra India 16 139 0.6× 58 0.4× 62 0.5× 146 2.6× 36 0.7× 25 571
Takashi Igarashi Japan 11 197 0.8× 111 0.7× 9 0.1× 38 0.7× 32 0.6× 26 425

Countries citing papers authored by G Clifton

Since Specialization
Citations

This map shows the geographic impact of G Clifton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Clifton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Clifton more than expected).

Fields of papers citing papers by G Clifton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Clifton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Clifton. The network helps show where G Clifton may publish in the future.

Co-authorship network of co-authors of G Clifton

This figure shows the co-authorship network connecting the top 25 collaborators of G Clifton. A scholar is included among the top collaborators of G Clifton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Clifton. G Clifton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clifton, G, et al.. (1990). The Effects of Mercuric Chloride on Calmodulin-Mediated CA+2 Transport in Rat Brain. The American Journal of the Medical Sciences. 299(1). 26–31. 1 indexed citations
2.
Clifton, G, Ramón Vargas, Roger Williams, et al.. (1990). Pharmacokinetics, pharmacodynamics, and minimum effective clinical dose of intravenous nicardipine. Clinical Pharmacology & Therapeutics. 47(6). 706–718. 32 indexed citations
3.
Harrison‐Bernard, Lisa M., et al.. (1990). Renal Versus Hindquarter Hemodynamic Responses to Vasopressin in Conscious Rats. Journal of Cardiovascular Pharmacology. 16(5). 719–726. 5 indexed citations
4.
Clifton, G, et al.. (1989). The effects of enoximone on renal function in patients with congestive heart failure. Clinical Pharmacology & Therapeutics. 45(1). 85–91. 7 indexed citations
5.
Clifton, G, et al.. (1989). Monoexponential Analysis of Plasma Disappearance of 99mTc‐DTPA and 131I‐Iodohippurate: A Reliable Method for Measuring Changes of Renal Function. The Journal of Clinical Pharmacology. 29(5). 466–471. 1 indexed citations
6.
Clifton, G, et al.. (1989). The Renal Function and Blood Pressure Effects of Dilevalol in the Normotensive and Hypertensive Elderly. The Journal of Clinical Pharmacology. 29(7). 603–608. 2 indexed citations
7.
Clifton, G, et al.. (1989). Intravenous nicardipine in severe systemic hypertension. The American Journal of Cardiology. 64(15). H16–H18. 13 indexed citations
8.
Clifton, G, et al.. (1989). Effects of dilevalol on renal function. The American Journal of Cardiology. 63(19). I75–I78. 4 indexed citations
9.
Wallin, John D., et al.. (1988). Intravenous nicardipine for the treatment of severe hypertension. The American Journal of Medicine. 85(3). 331–338. 55 indexed citations
10.
Wallin, John D., et al.. (1988). Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity. Clinical Pharmacology & Therapeutics. 43(4). 393–399. 14 indexed citations
11.
Harrison‐Bernard, Lisa M., et al.. (1988). Hemodynamic responses to vasopressinergic antagonism in water-deprived conscious rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 255(1). R46–R51. 5 indexed citations
12.
Clifton, G, et al.. (1986). Mercuric chloride inhibition of vasopressin release from the isolated neurointermediate lobe of the rat pituitary. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 887(2). 189–195. 4 indexed citations
13.
Smith, William, G Clifton, William M. OʼNeill, & John D. Wallin. (1983). Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.. Hypertension. 5(4). 579–583. 18 indexed citations
14.
OʼNeill, William M., et al.. (1981). Effects of labetalol and methyldopa on renal function. Clinical Pharmacology & Therapeutics. 30(1). 57–63. 15 indexed citations
15.
Clifton, G & Neil Kaplowitz. (1978). Effect of dietary phenobarbital, 3,4-benzo(α)pyrene and 3-methyl-cholanthrene on hepatic, intestinal and renal glutathione S-transferase activities in the rat. Biochemical Pharmacology. 27(8). 1284–1287. 55 indexed citations
16.
Clifton, G & Neil Kaplowitz. (1977). The glutathione S-transferases of the small intestine in the rat.. PubMed. 37(3). 788–91. 51 indexed citations
17.
Kaplowitz, Neil, G Clifton, J Kuhlenkamp, & John D. Wallin. (1976). Comparison of renal and hepatic glutathione S-transferases in the rat. Biochemical Journal. 158(2). 243–248. 30 indexed citations
18.
Kaplowitz, Neil, et al.. (1975). Drug induction of hepatic glutathione S-transferases in male and female rats. Biochemical Journal. 146(2). 351–356. 138 indexed citations
19.
Clifton, G, Neil Kaplowitz, John D. Wallin, & J Kuhlenkamp. (1975). Drug induction and sex differences of renal glutathione S-transferases in the rat. Biochemical Journal. 150(2). 259–262. 38 indexed citations
20.
Kaplowitz, Neil, J Kuhlenkamp, & G Clifton. (1975). Hepatic Glutathione S-Transferases: Identification by Gel Filtration and in Vitro Inhibition by Organic Anions. Experimental Biology and Medicine. 149(1). 234–237. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026